R2 Technologies - Our Story

Tim Holt is President and CEO of R2 Technologies, headquar-tered in San Ramon, California. R2 is currently developing breakthrough CryoAesthetic technologies that will launch in the US and China markets in early 2021. Tim has 17 years of commercial experience in the aesthetic medical device industry which includes key leadership roles at Reliant Technologies and ZELTIQ. He was at the forefront of the successful product launches of Fraxel and CoolSculpting as well as the growth and scaling of those two ventures from start-up to IPO/acquisition. R2 will be Tim’s third successive company delivering a
game-changing product to market that originated in the labs of world-renowned serial inventors, Drs. Rox Anderson, Dieter Manstein and Henry Chan.

Tim is a native of Ohio. He received his BBA in Marketing from Ohio University in 1997 and his MBA from Campbell University in 1999. He has been involved in various youth mentorship and philanthropic organizations. He is a member of the Ohio University Executive Advisory Board, he’s a sponsor of the Ohio University Select Leaders Program and he’s an Ambassador for the Gratitude Network.

Kristine has dedicated her 25-year career to cryobiology research and the development of cold-based medical devices. She held a leadership position at ZELTIQ and dedicated the last decade to aesthetic applications for cold therapies.

Mike has 20 years of experience helping healthcare companies bring innovative technologies to market. Mike’s career began at Johnson & Johnson in operations and commercial roles. More recently, he held commercial roles at Biolux Research, Elira, and ZELTIQ.

Pete comes to R2 with over 20 years of sales leadership experience in aesthetic device, dental, and software technology. He led the Southeast US teams at Thermage and Solta Medical to award winning performances with brands such as Thermage, Fraxel, Isolaz, and Clear + Brilliant.

As the General Manager for distributors Patterson Dental and Benco Dental, he led business units up to $50M in annual sales revenues.

Most recently, Pete led the US sales efforts at startup fintech provider HintMD, growing the business from zero to over $250M in annual processing sales. HintMD was successfully acquired by Revance Aesthetics in July 2020.

Roger has been in the pharmaceutical/medical device industry for over 20 years. He jumped into aesthetic medicine in 2012 with ZELTIQ, assuming the role as Managing Director of APAC for CoolSculpting. He then moved on to miraDry where he built and managed the APAC, Middle East and LATAM business.

Casey has 20+ years’ experience leading high performing teams in sales operations, customer service, and logistics in the medical aesthetics and life science industries. Most recently with ZELTIQ where he helped to launch the CoolSculpting brand and commercial programs.

For the last 20 years, Ragan has worked in the high-tech and medtech industry. She has been instrumental in multiple stages of the IPO process, most recently with ZELTIQ.

Angell is a CPA and FP&A with 20 years of both public and private company experience. She brings a wide breadth of accounting and finance knowledge.